DeutschNewstral
Article
Haaretz on 2016-06-14 00:30
Business in Brief: India’s Dr. Reddy’s to Buy Eight Generic Drugs From Teva and Allergan
Related news
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com- The Ticker: Teva in Generic Tie-up With Japan’s TakedaHaaretz
- FAllergan sells generic drugs unit to Tevaft.com
- Business in Brief: Teva Pushes Back Completion of Allergan Deal to JuneHaaretz
- HTeva Revenue Loss Amid Generic Competitionhamodia.com
Israel's Teva buys Allergan generic drug company for $40.5BMerced Sun-Star
Teva buys Allergan generic drug firm for $40.5BUSA today
Israel’s Teva buys Allergan generic drug company for $40.5Breviewtimes.com
Israel’s Teva buys Allergan generic drug company for $40.5 billionpressherald.com
Teva buys Allergan generic drug company for $40.5BChicago Tribune- Business in Brief / Teva secures $33.75b loan for Allergan dealHaaretz